Pharmacyclics – Raising the Standard in 1L CLL
Presented by: Tara Ference, RN, BSN, Hematology Clinical Account Specialist

Pfizer- Pfizer Oncology Together - A Patient Support Program
Presented by: Mark Weibell, MA, CPC, Field Reimbursement Manager

Incyte - Jakafi® (ruxolitinib) Value Proposition
Presented by: Nicolas Kuehl, National Account Manager

Takeda – Takeda Oncology Patient Services
Presented by: Nicole Witts, MBA, Regional Account Executive

BeiGene – BeiGene Corporate Overview
Presented by: Jeff Wilhour, Director, Market Access, and Hoa Pham, Pharm. D -Sr. Director-Medical Affairs

Dova Pharmaceuticals - Avatrombopag in ITP
Presented by: Sarica Klein, PharmD, Associate Director Medical Affairs

Exact Sciences - Oncotype DX Breast Recurrence Score Test -Tailoring Treatment for Early-Stage, ER-Positive, HER2-Negative Breast Cancer in the Era of Precision Medicine
Presented by: George Demos, MBA, Senior Regional Oncogenomic Liaison

Natera- A Discussion On: Optimizing Management of Patients with CRC
Presented by: Shifra Krinshpun, MS, LCGC, Sr. Medical Science Liaison

Eisai - Lenvima multi invitation usage for HCC, EC, DTC and RCC.
Presented by: Stephanie Tresp, Oncology Sales Specialist

EMD Serono - Bavencio 1^st Line UC Maintenance Therapy
Presented by: Kim Zygadlo, MS; Access Account Manager